Sumitomo Chemical India Ltd (SUMICHEM) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Sumitomo Chemical India achieved 20% volume growth in its branded domestic business and over 13% volume growth in exports during FY24-25.
- The company achieved its highest ever profitability in FY24-25 in terms of both absolute value and percentage margin.
- Several new product launches in the last three years contributed significantly to the volume growth.
- The company is ready to launch several new products in FY25-26, including the patented global blockbuster product, Indiflame (branded as Excelia Max in India).
- Sumitomo is planning to manufacture the active ingredient for Indiflame in India within the next 12-15 months at its Tarapore plant.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.